Tech Center 1600 • Art Units: 1657
This examiner grants 58% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18274757 | ENGINEERED BACTERIA AND METHODS OF PRODUCING TRIACYLGLYCERIDES | Non-Final OA | PRESIDENT AND FELLOWS OF HARVARD COLLEGE |
| 17917427 | Keratin-Based Substrate and Methods of Forming the Same | Final Rejection | President and Fellows of Harvard College |
| 18346315 | NOVEL SYNTHETIC PATHWAY TO BELZUTIFAN | Non-Final OA | Merck Sharp & Dohme LLC |
| 18488913 | MICROBIAL CONSORTIUM AND USES THEREOF | Non-Final OA | The Regents of the University of California |
| 18455222 | REAL-TIME MONITORING OF MICROBIAL GROWTH IN WATER FLUID WELLS | Final Rejection | SAUDI ARABIAN OIL COMPANY |
| 18561144 | NOVEL TECHNOLOGY TO ENABLE SUCROSE UTILIZATION IN STRAINS FOR BIOSYNTHETIC PRODUCTION | Non-Final OA | DSM IP Assets B.V. |
| 17414839 | PHAGE RESISTANT LACTIC ACID BACTERIA | Non-Final OA | DSM IP ASSETS B.V. |
| 17469308 | METHOD FOR DETECTING HOST CELL PROTEINS IN THERAPEUTIC ANTIBODIES BY COMBINING TRYPSIN DIGESTION, CHROMATOGRAPHY GRADIENTS, AND BOXCAR MASS SPECTROMETRY | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 18255203 | ENGINEERED PROBIOTIC COMPOSITIONS AND USES THEREOF | Non-Final OA | MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
| 18670411 | METHOD FOR TREATMENT AND CONTROL OF PLANT DISEASE | Final Rejection | The Texas A&M University System |
| 18393145 | Preparation Method and Enrichment Method for Cyanidin-3-Diglucoside-5-Glucoside | Final Rejection | China Agricultural University |
| 18686227 | METHOD FOR PRODUCING PROTEIN MATERIAL WITHOUT USING ORGANIC SOLVENT | Non-Final OA | TOPPAN HOLDINGS INC. |
| 18165051 | METHODS AND COMPOSITIONS FOR THE DETECTION OF BETA-LACTAMASES | Final Rejection | Becton, Dickinson and Company |
| 18547256 | AN ARTIFICIAL TRAP-CAGE, ITS USE AND METHOD OF PREPARING THEREOF | Non-Final OA | UNIWERSYTET JAGIELLONSKI |
| 18685498 | NOVEL ACETOHYDROXY ACID SYNTHASE SUBUNIT VARIANT AND METHOD FOR PRODUCING L-VALINE USING SAME | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 17799051 | RECOMBINANT SILK SOLIDS AND FILMS | Final Rejection | BOLT THREADS, INC. |
| 18772100 | PRODUCT DERIVED FROM RHODOCOCCUS RUBER, AND PHARMACEUTICAL USE THEREOF | Final Rejection | LIAONING GREATEST BIO-PHARMACEUTICAL CO., LTD. |
| 18744627 | Microorganism Loaded Aggregate and Manufacturing Methods | Non-Final OA | Biomason Inc. |
| 17279259 | METHODS OF TREATING AND DIAGNOSING INFLAMMATORY BOWEL DISEASE | Non-Final OA | CEDARS-SINAI MEDICAL CENTER |
| 18329652 | METHOD FOR DETECTING AMMONIA NITROGEN CONTENT BY USING NITRIFICATION BIOLOGICAL REACTION | Final Rejection | WUYI UNIVERSITY |
| 18690504 | OVER EXPRESSION OF FOLDASES AND CHAPERONES IMPROVES PROTEIN PRODUCTION | Non-Final OA | DUPONT NUTRITION BIOSCIENCES APS |
| 18444307 | PROCESS FOR FRACTIONATION OF PHOTOSYNTHETIC BIOMASS AND RELATED SYSTEMS AND METHODS | Non-Final OA | Filament Biosciences, LLC. |
| 17912513 | INJECTABLE BOTULINUM TOXIN METHODS FOR TREATING HEADACHES | Final Rejection | Revance Therapeutics, Inc. |
| 18574497 | METHOD FOR PURIFYING CLOSTRIDIUM BOTULINUM TOXIN COMPLEX PROTEIN | Non-Final OA | PHARMA RESEARCH BIO CO., LTD. |
| 17610224 | Methods for production of strictosidine aglycone and monoterpenoid indole alkaloids | Non-Final OA | DANMARKS TEKNISKE UNIVERSITET |
| 18573298 | COMPOSITIONS OF BETA-HEXOSAMINIDASE VARIANTS AND USES THEREOF | Non-Final OA | BIOMARIN PHARMACEUTICAL INC. |
| 17273144 | METHOD OF PRODUCING DOCOSAHEXAENOIC ACID CONTAINING GLYCERIDE USING A LIPASE HYDROLYSIS REACTION | Final Rejection | Nissui Corporation |
| 18527538 | SUPPLEMENT COMPOSITION FOR CONSUMPTION BY INDIVIDUALS BEING ADMINISTERED A GLP-1 AGONIST | Non-Final OA | Food Sciences Corp. |
| 18037204 | TREATMENT OR PREVENTION OF HIV INFECTION | Final Rejection | Janssen Sciences Ireland Unlimited Company |
| 18012252 | PLASTIC POLYMER BIOCONVERSION PROCESS | Non-Final OA | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy